U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07792538) titled 'Psilocybin-Assisted Psychotherapy for Veterans With PTSD' on July 23.

Brief Summary: This study will evaluate the feasibility, safety and preliminary efficacy of psilocybin-assisted psychotherapy in military veterans with treatment-refractory posttraumatic stress disorder (PTSD).

Study Start Date: Dec., 2026

Study Type: INTERVENTIONAL

Condition: Posttraumatic Stress Disorder (PTSD)

Intervention: DRUG: Psilocybin-assisted Psychotherapy

Two psilocybin sessions (15 mg psilocybin in the first session; 25 mg psilocybin in the second session) embedded in a psychotherapeutic framework with three preparatory sessions and six integrat...